Table 3. Biotransformations of aryl ketones and aldehydes by E. coli whole cells expressing BVMOAFL838 (WC) and purified BVMOAFL838 (ENZ).
Substrate | Conversion (%) | TOF (s-1) | Km (mM) | |||
---|---|---|---|---|---|---|
WC_2h | ENZ_2h | ENZ_8h | 10 mM kobs | |||
6a | Acetophenone | 19 | 4 | 13 | 0.05 | 10.0 ± 1.2 |
7a | 4-Hydroxyacetophenone | 84 | >99 | >99 | 1.4 | 0.8 ± 0.05 |
8a | Phenylacetone | 72 | n.c. | n.c. | 0.28a | 2.4 ± 1.2a |
9a | 4-Phenyl-2-butanone | 64 | >99 | >99 | 2.4 | <0.01b |
10a | 4-(4-Hydroxyphenyl)-2-butanone | 85 | >99 | >99 | 2.8 | <0.01b |
11a | 4-(4-Methoxyphenyl)-2-butanone | 68 | 85 | 85 | 4.3 | <0.01b |
12a | Benzaldehyde | 62 | n.c. | n.c. | 0.03 | 6.5 ± 0.7 |
13a | 4-Methoxybenzaldehyde | 63 | 81 | 88 | 1.0 | 0.03 ± 0.002 |
a Determined using 2 μM of BVMO
b Substrate inhibition observed, Ki>>Km